Clinical significance of recurrent venous thromboembolism;Significância clínica de tromboembolismo venoso recorrente

Jornal Vascular Brasileiro

Volumn 9, Issue 2, 2010, Pages 72-75

  Labropoulos, Nicos ^a   Spentzouris, Georgios ^a   Sobreira, Marcone Lima ^b  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Anticoagulation; Postthrombotic syndrome; Pulmonary hypertension; Recurrent venous thromboembolism

Indexed keywords

ANTICOAGULANT AGENT; ANTIVITAMIN K; HEPARIN;

ANTICOAGULANT THERAPY; ARTICLE; BLOOD CLOT LYSIS; CLINICAL CLASSIFICATION; COMPRESSION GARMENT; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE DURATION; DISEASE SEVERITY; ECHOGRAPHY; FOLLOW UP; HIGH RISK PATIENT; HUMAN; LUNG EMBOLISM; MEDICAL HISTORY; MORTALITY; NUCLEAR MAGNETIC RESONANCE IMAGING; PATIENT ATTITUDE; POSTTHROMBOSIS SYNDROME; PULMONARY HYPERTENSION; QUALITY OF LIFE; RECURRENT DISEASE; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SENSITIVITY AND SPECIFICITY; SURVIVAL RATE; SYMPTOMATOLOGY; THROMBOSIS PREVENTION; TREATMENT DURATION; TREATMENT INDICATION;

EID: 77958122307     PISSN: 16775449     EISSN: 16775449     Source Type: Journal    
DOI: 10.1590/S1677-54492010000200010     Document Type: Article

References (24)

1. Prandoni P, Noventa F, Ghirarduzzi A, et al. The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism. A prospective cohort study in 1,626 patients. Haematologica. 2007;92:199-205.
2. Pradoni P, Lensing AW, Cogo A, et al. The long term clinical course of acute deep venous thrombosis. Ann Intern Med. 1996;125:1-7.
3. Labropoulos N, Gasparis AP, Tassiopoulos AK. Prospective evaluation of the clinical deterioration in post-thrombotic limbs. J Vasc Surg. 2009;50:826-830.
4. Abai B, Labropoulos N. Duplex ultrasound scanning for chronic venous obstruction and valvular incompetence. In: Gloviczki P, ed. Hanbook of venous disorders. London: Hodder Arnold; 2009. p. 142-155.
5. Labropoulos N, Tiongson J, Pryor L, et al. Definition of venous reflux in lower-extremity veins. J Vasc Surg. 2003;38:793-798.
6. Prandoni P, Lensing AW, Bernardi E, Villalta S, Bagatella P, Girolami A. The diagnostic value of compression ultrasonography in patients with suspected recurrent deep vein Thrombosis. Thromb Haemost. 2002;88:402-406.
7. Linkins LA, Pasquale P, Paterson S, Kearon C. Change in thrombus length on venous ultrasound and recurrent deep vein thrombosis. Arch Intern Med. 2004;164:1793-1796.
8. Rosen CL, Tracy JA. The diagnosis of lower extremity deep venous thrombosis. Emerg Med Clin North Am. 2001;19:895-912.
9. Carpenter JP, Holland GA, Baum RA, Owen RS, Carpenter JT, Cope C. Magnetic resonance venography for the detection of deep venous thrombosis: comparison with contrast venography and duplex Doppler ultrasonography. J Vasc Surg. 1993;18:734-741.
10. Froehlich JB, Prince MR, Greenfield LJ, Downing LJ, Shah NL, Wakefield TW. "Bull's-eye" sign on gadolinium-enhanced magnetic resonance venography determines thrombus presence and age: a preliminary study. J Vasc Surg. 1997;26:809-816.
11. Labropoulos N, Waggoner T, Sammis W, Samali S, Pappas PJ. The effect of venous thrombus location and extent on the development of post-thrombotic signs and symptoms. J Vasc Surg. 2008;48:407-412.
12. Roumen-Klappe EM, den Heijer M, Janssen MC, van der Vleuten C, Thien T, Wollersheim H. The post-thrombotic syndrome: incidence and prognostic value of non-invasive venous examinations in a six-year follow-up study. Thromb Haemost. 2005;94:825-830.
13. Kahn SR, Shrier I, Julian JA, et al. Determinants and time course of the postthrombotic syndrome after acute deep venous thrombosis. Ann Intern Med. 2008;149:698-707.
14. Prandoni P, Kahn SR. Post-thrombotic syndrome: prevalence, prognostication and need for progress. Br J Haematol. 2009;145:286-295.
15. Fedullo PF, Auger W, Kerr K, Rubin LJ. Chronic thromboembolic pulmonary hypertension. N Engl J Med. 2001;345:1465-1472.
16. Hoeper MM, Mayer E, Simonneau G, Rubin LJ. Chronic thromboembolic pulmonary hypertension. Circulation. 2006;113:2011-2020.
17. Büller Hr, Agnelli G, Hull RD, Hyers TM, Prins MH, Raskob GE. Antithrombotic therapy for venous thromboembolic disease: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004;126(Suppl 3):401S-428S.
18. Fanikos J, Piazza G, Zayaruzny M, Goldhaber SZ. Long-term complications of medical patients with hospital-acquired venous thromboembolism. Thromb Haemost. 2009;102:688-693.
19. Kearon C, Kahn SR, Agnelli G, Goldhaber S, Raskob GE, Comerota AJ. Antithrombotic therapy for venous thromboembolic disease: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest. 2008;133(Suppl 6):454s-545s.
20. van Dongen CJ, Prandoni P, Frulla M, Marchiori A, Prins MH, Hutten BA. Relation between quality of anticoagulant treatment and the development of the postthrombotic syndrome. J Thromb Haemost. 2005;3:939-942.
21. Giannoukas AD, Labropoulos N, Michaels JA. Compression with or without early ambulation in the prevention of post-thrombotic syndrome. Eur J Vasc Endovasc Surg. 2006;32:217-221.
22. Prandoni P, Lensing AW, Prins MH, et al. Residual venous thrombosis as a predictive factor of recurrent venous thromboembolism. Ann Intern Med. 2002;137:955-960.
23. Cuff RF. Screening and surveillance for deep vein thrombosis in high-risk patients. In: Labropoulos N, Mansour MA, eds. Vascular Diagnosis. Philadelphia: Elsevier Saunders; 2005. p. 463-467.
24. Spencer FA, Gore JM, Lessard D, Douketis JD, Emery C, Goldberg RJ. Patient outcomes after deep vein thrombosis and pulmonary embolism. Arch Intern Med. 2008;168:425-430.